Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136

NCT00751348 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

475

Enrollment

INDUSTRY

Sponsor class

Conditions

Measles
Varicella
Mumps
Rubella

Interventions

BIOLOGICAL: PriorixTM
BIOLOGICAL: VarilrixTM
BIOLOGICAL: Priorix-Tetra®

Sponsor

GlaxoSmithKline